Blackburn Kelly has filed 3 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 30000 shares of CervoMed Inc. ($CRVO) on February 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | CervoMed Inc. | $CRVO | Blackburn Kelly | EVP, Clinical Development | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 9,252,719 | 9999.99% | 0.32% |
| Feb. 4, 2025 | CervoMed Inc. | $CRVO | Blackburn Kelly | SVP, Clinical Development | A | Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | CervoMed Inc. | $CRVO | Blackburn Kelly | SVP, Clinical Development | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |